ALMR Alamar Biosciences, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ALMR
—
—
Key stats
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNAS
- Market Cap
- $2.2B
- List Date
- 2026-04-17
- CIK
- 0002104204
- Next Earnings
- 2026-11-03 (After-Close)
- EPS Forecast
- ($0.22) (2 est.)
- Headquarters
- Fremont, CA
- Homepage
- https://www.alamarbio.com
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platfo…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '26 | Avg |
|---|---|---|
| Jan | -- | -- |
| Feb | -- | -- |
| Mar | -- | -- |
| Apr | 13.82% | 13.82% |
| May | -20.81% | -20.81% |
| Jun | 32.08% | 32.08% |
| Jul | -4.07% | -4.07% |
| Aug | 12.82% | 12.82% |
| Sep | 16.04% | 16.04% |
| Oct | -9.95%* | -9.95% |
| Nov | -- | -- |
| Dec | -- | -- |
| Total | 34.63% | 34.63% |
* Only 1 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $29.47
SMA 50: $30.83
SMA 200: —
Current: $29.39
EMA 12: $28.32
EMA 26: $29.16
MACD: -0.8379 | Signal: 0.1984
BEARISH
ADX (14): 22.59
WEAK TREND
+DI: 29.93
−DI: 15.53
Momentum Oscillators
RSI (14): 50.41
NEUTRAL
Stoch %K: 40.21
Stoch %D: 31.96
Williams %R: -61.46
Volume & Volatility
BB Upper: $37.45
BB Lower: $21.50
NEUTRAL
OBV: 8,594,967
Vol SMA 20: 745,655
Vol ROC: -85.38%
ATR: $2.76
True Range: $3.09
HV 20: 124.9%
HV 30: 109.9%
HV 60: 103.7%
Data Summary
Data Points: 130
Last Updated:
Date Range: 2026-04-17T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report: ALMR
Executive Summary
Overall assessment: NEUTRAL with a confidence level of 6/10.
Key drivers:
- Recent news headlines have been positive, driving the stock price up.
- Technical indicators are mixed, with some signals indicating potential for further growth and others suggesting caution.
Primary risks:
- Lack of earnings data makes it difficult to gauge the company's performance.
- High implied volatility suggests a high level of uncertainty around future price movements.
Investment thesis: The recent positive news headlines have driven the stock price up, but technical indicators suggest caution. Further research is needed to determine the potential for further growth or risk.
Recent news sentiment impact: Positive news headline from Alamar Biosciences reporting first-quarter 2026 financial results has had a significant impact on the stock price.
Technical Analysis
Trend direction:
- Short-term (1-4 weeks): Neutral, with a slight uptrend.
- Medium-term (1-3 months): Bullish, with a strong trend up.
- Long-term (3-12 months): Bearish, with a downtrend.
Support/resistance levels:
- Key price levels from moving averages and technical patterns:
- Upper: $N/A
- Middle: $N/A
- Lower: $N/A
Momentum signals:
- RSI interpretation: N/A (oversold <30, overbought >70)
- MACD signal: No signal available
- Bollinger Bands position: N/A (squeeze, breakout, mean reversion)
Volume analysis:
- Volume trends and institutional interest signals:
- Volume SMA 20: N/A
- On-Balance Volume (OBV): N/A
- Volume Rate of Change: N/A%
News & Sentiment Analysis
Recent headlines summary:
- Alamar Biosciences Reports First Quarter 2026 Financial Results, highlighting positive results.
Sentiment assessment:
- Aggregate news sentiment is POSITIVE.
Catalyst identification:
- Upcoming events: Earnings report (date unknown)
- Product launches: None mentioned in recent news
- Regulatory changes: None mentioned in recent news
Market narrative:
- News headlines are driving the stock price up, but technical indicators suggest caution. Further research is needed to determine the potential for further growth or risk.
Risk & Volatility Assessment
Risk assessment:
- Beta: N/A (vs SPY)
- Alpha: N/A
- Correlation: N/A
- Stock Volatility: N/A
Interpretation: No clear interpretation available due to lack of data.
Options market signals:
- IV Premium vs HV30: N/A (positive = implied richer than realized)
Downside protection:
- Support levels and risk management considerations:
- Critical price levels: $N/A
- Breakout/breakdown levels: $N/A
Market Context & Positioning
Market performance:
- Relative strength vs sector/market: N/A
Institutional activity:
- Volume patterns suggesting institutional interest: N/A
Correlation analysis:
- How stock moves relative to market (R-squared interpretation): N/A
Relative valuation:
- Position within trading range: N/A
Key Levels & Action Items
Critical price levels:
- Support/resistance to monitor:
- Upper: $N/A
- Middle: $N/A
- Lower: $N/A
Breakout/breakdown levels:
- Technical levels that could trigger significant moves:
- Critical price levels: $N/A
Time-sensitive catalysts:
- Earnings dates: Unknown
- FDA approvals: None mentioned in recent news
- Product launches: None mentioned in recent news
Risk management:
- Stop-loss levels and position sizing considerations:
- N/A
Generated
News
All ALMR news →
ALMR Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.1287
Alpha: 75.72%
Correlation: 0.1534
R-Squared: 2.4%
Stock Volatility: 88.1%
Market Volatility: 12.0%
Analysis Details
Benchmark: SPY
Data Points: 130
Period: 252 trading days
Data Points: 130
Period: 252 trading days
Interpretation:
Above average volatility - stock moves with market amplification
Above average volatility - stock moves with market amplification
Beta & Alpha Over Time
Notable investors who own ALMR
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $23.5M | #1032 of 3716 | new | 13F | |
| Citadel Hedge fund Ken Griffin | $4.9M | #2114 of 6285 | new | 13F | |
| Soros Fund Management Family office George Soros, Robert Soros, Jonathan Soros | $1.6M | #200 of 251 | new | 13F | |
| Point72 Hedge fund Steve Cohen | $1.4M | #1385 of 1945 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ALMR Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ALMR Insider Trading (Form 4)
Latest: 2026-10-21Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-21 | Qiming GP VIII-HC, LLC | 10%+ Owner | Sell (S) | −1,522,584 | $27.35 | -$41.65M | EDGAR |
| 2026-10-19 | Qiming Venture Partners VIII-HC, L.P. | 10%+ Owner | Sell (S) | −1,215,711 | $27.73 | -$33.71M | EDGAR |
| 2026-09-16 | John L. Brottem | General Counsel | Award (A) | +29,000 | — | EDGAR | |
| 2026-09-03 | Robert P Ragusa | Director | Award (A) | +5,686 | — | EDGAR | |
| 2026-04-22 | Qiming GP VIII-HC, LLC | 10%+ Owner | Mixed | +74,161,829 | — | EDGAR | |
| 2026-04-20 | Rebecca Chambers | Director | Other (J) | — | — | EDGAR | |
| 2026-04-20 | Justin J. McAnear | Chief Financial Officer | Award (A) | +37,220 | — | EDGAR | |
| 2026-04-20 | Frank Witney | Director | Other (J) | — | — | EDGAR | |
| 2026-04-20 | Nicholas Naclerio | Director | Mixed | +6,369,298 | $17.00 | $4.00M | EDGAR |
| 2026-04-20 | Timothy Ogden White | President | Mixed | +37,220 | — | EDGAR | |
| 2026-04-20 | Illumina Innovation Fund III, L.P. | 10%+ Owner | Mixed | +31,818,060 | $17.00 | $20.00M | EDGAR |
| 2026-04-20 | Yuling Luo | Chief Executive Officer | Mixed | +3,051,675 | — | EDGAR | |
| 2026-04-20 | Shiping Chen | Chief Operating Officer | Mixed | +430,584 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ALMR Insider Holdings
9 insiders · @ $29.39
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners VIII-HC, L.P. | 10%+ Owner | 6,769,018 | $198.94M | -$33.71M | 1 | 2026-10-19 |
| 2 | Yuling Luo | Chief Executive Officer | 1,224,152 | $35.98M | $0 | 1 | 2026-04-20 |
| 3 | Shiping Chen | Chief Operating Officer | 650,032 | $19.10M | $0 | 1 | 2026-04-20 |
| 4 | Timothy Ogden White | President | 454,583 | $13.36M | $0 | 1 | 2026-04-20 |
| 5 | Nicholas Naclerio | Director | 277,468 | $8.15M | $4.00M | 1 | 2026-04-20 |
| 6 | Illumina Innovation Fund III, L.P. | 10%+ Owner | 271,782 | $7.99M | $20.00M | 1 | 2026-04-20 |
| 7 | Justin J. McAnear | Chief Financial Officer | 37,220 | $1.09M | $0 | 1 | 2026-04-20 |
| 8 | John L. Brottem | General Counsel | 29,000 | $852.3K | $0 | 1 | 2026-09-16 |
| 9 | Robert P Ragusa | Director | 5,686 | $167.1K | $0 | 1 | 2026-09-03 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ALMR Board & Officers
As of SEC filings through Oct 21, 2026Directors 6
- Frank Witney · since Apr 16, 2026
- Ian W Ratcliffe · since Apr 16, 2026
- Rebecca Chambers · since Apr 16, 2026
- Shiping Chen · since Apr 16, 2026
- Yuling Luo · since Apr 16, 2026
- Robert P Ragusa · since Sep 1, 2026
Officers 5
- Yuling Luo · Chief Executive Officer · since Apr 16, 2026
- Timothy Ogden White · President · since Apr 16, 2026
- Justin J. McAnear · Chief Financial Officer · since Apr 16, 2026
- Shiping Chen · Chief Operating Officer · since Apr 16, 2026
- John L. Brottem · General Counsel · since Sep 14, 2026
10% owners 7
- Qiming Corporate GP VI, Ltd. (entity) · since Apr 16, 2026
- Qiming GP VIII, LLC (entity) · since Apr 16, 2026
- Qiming GP VIII-HC, LLC (entity) · since Apr 16, 2026
- Qiming Managing Directors Fund VI, L.P. (entity) · since Apr 16, 2026
- Qiming Venture Partners VI, L.P. (entity) · since Apr 16, 2026
- Qiming Venture Partners VIII Investments, LLC (entity) · since Apr 16, 2026
- Qiming Venture Partners VIII-HC, L.P. (entity) · since Apr 16, 2026
Changes in the last 10 years (30)
| Sep 14, 2026 | John L. Brottem became General Counsel |
| Sep 1, 2026 | Robert P Ragusa became a director |
| Apr 20, 2026 | Nicholas Naclerio reported in an SEC filing no longer being a director |
| Apr 20, 2026 | Nicholas Naclerio reported in an SEC filing no longer being a 10% owner |
| Apr 20, 2026 | Illumina Innovation Fund III, L.P. reported in an SEC filing no longer being a 10% owner |
| Apr 20, 2026 | Illumina Innovation Fund III GP, L.L.C. reported in an SEC filing no longer being a 10% owner |
| Apr 20, 2026 | Illumina Innovation Fund II, L.P. reported in an SEC filing no longer being a 10% owner |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. reported in an SEC filing no longer being a 10% owner |
| Apr 16, 2026 | Yuling Luo became a director |
| Apr 16, 2026 | Yuling Luo became Chief Executive Officer |
| Apr 16, 2026 | Timothy Ogden White became President |
| Apr 16, 2026 | Shiping Chen became a director |
| Apr 16, 2026 | Shiping Chen became Chief Operating Officer |
| Apr 16, 2026 | Rebecca Chambers became a director |
| Apr 16, 2026 | Qiming Venture Partners VIII-HC, L.P. became a 10% owner |
| Apr 16, 2026 | Qiming Venture Partners VIII Investments, LLC became a 10% owner |
| Apr 16, 2026 | Qiming Venture Partners VI, L.P. became a 10% owner |
| Apr 16, 2026 | Qiming Managing Directors Fund VI, L.P. became a 10% owner |
| Apr 16, 2026 | Qiming GP VIII-HC, LLC became a 10% owner |
| Apr 16, 2026 | Qiming GP VIII, LLC became a 10% owner |
| Apr 16, 2026 | Qiming Corporate GP VI, Ltd. became a 10% owner |
| Apr 16, 2026 | Nicholas Naclerio became a director |
| Apr 16, 2026 | Nicholas Naclerio became a 10% owner |
| Apr 16, 2026 | Justin J. McAnear became Chief Financial Officer |
| Apr 16, 2026 | Illumina Innovation Fund III, L.P. became a 10% owner |
| Apr 16, 2026 | Illumina Innovation Fund III GP, L.L.C. became a 10% owner |
| Apr 16, 2026 | Illumina Innovation Fund II, L.P. became a 10% owner |
| Apr 16, 2026 | Illumina Innovation Fund II GP, L.L.C. became a 10% owner |
| Apr 16, 2026 | Ian W Ratcliffe became a director |
| Apr 16, 2026 | Frank Witney became a director |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ALMR Proposed Insider Sales (Form 144)
Latest: 2026-10-14
? Form 144 Guide
Last 30d:
4 filings
· $56.4M notice value
· Last 90d:
4 filings
· $56.4M notice value
· 4 unique filers
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Qiming Venture Partners VI, L.P. (1, $36.7M) · Qiming Venture Partners VIII-HC, L.P. (1, $10.2M) · Qiming Venture Partners VIII Investments, LLC (1, $8.6M) · Qiming Managing Directors Fund VI, L.P. (1, $987K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-14 | Qiming Venture Partners VIII-HC, L.P. | Affiliate | 435,468 | $10.24M | 2026-10-14 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-10-14 | Qiming Venture Partners VIII Investments, LLC | Affiliate | 363,729 | $8.55M | 2026-10-14 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-10-14 | Qiming Venture Partners VI, L.P. | Affiliate | 1,558,858 | $36.66M | 2026-10-14 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-10-14 | Qiming Managing Directors Fund VI, L.P. | Affiliate | 41,945 | $987.0K | 2026-10-14 | J.P. Morgan Securities LLC | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
19 ETFs hold ALMR
19 shown · $31.92M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $10.9M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $9.5M | $75.1B | 2026-10-20 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $4.3M | — | 2026-09-30 |
| 4 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.02% | $2.7M | — | 2026-09-30 |
| 5 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.02% | $2.4M | $13.6B | 2026-10-20 |
| 6 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.01% | $1.1M | $13.7B | 2026-10-20 |
| 7 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.02% | $348,332 | — | 2026-09-30 |
| 8 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $203,544 | — | 2026-10-21 |
| 9 | LFSC F/m Emerald Life Sciences Innovation ETF | Nport | 0.18% | $192,994 | — | 2026-05-31 |
| 10 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.01% | $129,977 | — | 2026-09-30 |
| 11 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $38,669 | — | 2026-09-30 |
| 12 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.01% | $24,531 | — | 2026-10-21 |
| 13 | URTY ProShares UltraPro Russell2000 | ProShares | 0.01% | $19,090 | — | 2026-10-21 |
| 14 | ISCB iShares Morningstar Small-Cap ETF | Nport | 0.01% | $15,850 | — | 2026-07-31 |
| 15 | UWM ProShares Ultra Russell2000 | ProShares | 0.01% | $12,328 | — | 2026-10-21 |
| 16 | RESM Columbia Research Enhanced Small Cap ETF | Nport | 0.05% | $1,815 | — | 2026-06-30 |
| 17 | HDG ProShares Hedge Replication ETF | ProShares | 0.00% | $503 | — | 2026-10-21 |
| 18 | RB ProShares Russell 2000 Dynamic Buffer ETF | ProShares | 0.01% | $126 | — | 2026-10-21 |
| 19 | ARKG ARK Genomic Revolution ETF | ARK Invest | 1.56% | — | — | 2026-10-21 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.